Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine-Reference-Cited by-同舟云学术

Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine

Published:2018-04-24 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Christiansen D.,Earnest-Silveira L.,Chua B.,Meuleman P.,Boo I.,Grubor-Bauk B.,Jackson D. C.,Keck Z. Y.,Foung S. K. H.,Drummer H. E.,Gowans E. J.,Torresi J.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-24762-9.pdf

Reference55 articles.

1. Midgard, H. et al. Hepatitis C reinfection after sustained virological response. Journal of Hepatology 64, 1020–1026, https://doi.org/10.1016/j.jhep.2016.01.001 (2016).

2. Sacks-Davis, R. et al. High rates of hepatitis C virus reinfection and spontaneous clearance of reinfection in people who inject drugs: a prospective cohort study. PLoS One 8, e80216, https://doi.org/10.1371/journal.pone.0080216 (2013).

3. Grebely, J. et al. Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine. The Lancet infectious diseases 12, 408–414, https://doi.org/10.1016/S1473-3099(12)70010-5 (2012).

4. Osburn, W. O. et al. Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection. Gastroenterology 138, 315–324, https://doi.org/10.1053/j.gastro.2009.09.017 (2010).

5. Aitken, C. K. et al. High incidence of hepatitis C virus reinfection in a cohort of injecting drug users. Hepatology 48, 1746–1752, https://doi.org/10.1002/hep.22534 (2008).

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is there still hope for the prophylactic hepatitis C vaccine? A review of different approaches;Journal of Medical Virology;2024-09

2. Update on Hepatitis C Vaccine: Results and Challenges;Viruses;2024-08-21

3. Exploring T-Cell Immunity to Hepatitis C Virus: Insights from Different Vaccine and Antigen Presentation Strategies;Vaccines;2024-08-06

4. Bioreactor for hepatitis C virus vaccine;Bioreactor Design Concepts for Viral Vaccine Production;2024

5. Nanoparticles and Antiviral Vaccines;Vaccines;2023-12-27